Anthem, Inc. (ANTM)
(Delayed Data from NYSE)
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMWe use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$261.70 USD
+0.11 (0.04%)
Updated May 3, 2019 04:00 PM ET
After-Market: $261.69 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGM
Zacks News
Anthem's (ANTM) Q4 Earnings Miss Estimates, Rise Y/Y
by Zacks Equity Research
Anthem's (ANTM) fourth-quarter results reflect solid revenues, partially offset by increased expenses.
Anthem (ANTM) Misses Q4 Earnings Estimates
by Zacks Equity Research
Anthem (ANTM) delivered earnings and revenue surprises of -0.51% and 1.04%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Anthem (ANTM) Gears Up for Q4 Earnings: What's in Store?
by Zacks Equity Research
Anthem's (ANTM) fourth-quarter results are likely to reflect a strong revenue stream.
Anthem (ANTM) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Anthem (ANTM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Healthcare in Retirement: Personal Finance 101
by Madeleine Johnson
Like all retirement-related things, healthcare is very important to plan for (financially and emotionally). Here's what retirees need to know about healthcare in your nest egg years.
Is Anthem (ANTM) A Suitable Pick for Value Investors Now?
by Zacks Equity Research
Is Anthem (ANTM) a great pick from the value investor's perspective right now? Read on to know more.
Cigna, Oscar Team Up to Offer Health Aids to Small Businesses
by Zacks Equity Research
Cigna (CI) partners with Oscar to provide health solutions for small businesses.
Is Anthem (ANTM) a Great Value Stock Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Molina Healthcare to Boost Medicaid Via Strategic Buyout
by Zacks Equity Research
Molina Healthcare (MOH) aims to scale up its Medicaid business by acquiring NextLevel Health.
Why Should You Stay Away from Magellan Health (MGLN) Now?
by Sapna Bagaria
Pressure on revenues and earnings along with low profitability makes Magellan Health (MGLN) an unattractive stock now.
Magellan Health's Arm Expands Its Suite of Health Solutions
by Zacks Equity Research
Magellan Health's (MGLN) subsidiary Magellan Complete Care of Virginia adds to its range of services to help patients achieve better health outcomes.
Will UnitedHealth Exhibit Strong Share Price Gains in 2020?
by Zacks Equity Research
UnitedHealth (UNH) will continue to show operating efficiency in 2020 but its shares might be subject to volatility due to regulatory ambiguity through 2020 elections.
Cigna Lags Industry in '19: Can Efforts Aid Recovery in 2020?
by Sapna Bagaria
Cigna's (CI) business streamlining and acquisitions are expected to drive growth in 2020.
Humana (HUM) Grows on Strong Medicare Business Expansion
by Zacks Equity Research
Humana (HUM) thrives well on the back of its well-performing Medicare business.
WellCare Health, Fitbit Collaborate to Aid Diabetes Patients
by Zacks Equity Research
WellCare Health (WCG) and Fitbit team up to encourage Georgia-based WellCare Medicaid members to manage their diabetic condition.
Humana (HUM) to Take Over Enclara for Enriched Healthcare
by Zacks Equity Research
Humana (HUM) to acquire hospice pharmacy Enclara Healthcare for boosting its capabilities.
HMO Industry Outlook: Multiple Levers to Drive Growth
by Sapna Bagaria
Aging U.S population, consolidation, use of technology and growing health service businesses provide ample scope for the industry to grow.
Anthem (ANTM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Anthem (ANTM) closed at $280.60 in the latest trading session, marking a -1.14% move from the prior day.
Why Should You Retain Anthem (ANTM) Stock in Your Portfolio?
by Zacks Equity Research
Riding high on a growing top line and higher membership, Anthem (ANTM) holds enough potential to reap benefits for investors.
Anthem (ANTM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Anthem (ANTM) closed the most recent trading day at $286.39, moving -0.34% from the previous trading session.
Here's Why Select Medical (SEM) Stock Looks Attractive
by Sapna Bagaria
Select Medical (SEM) benefits from revenue growth, acquisitions, and strong earnings guidance.
UnitedHealth (UNH) Provides Guidance for 2020, Shares Fall
by Sapna Bagaria
UnitedHealth's (UNH) guidance for 2020 indicates revenue and earnings growth but it is believed to be conservative, leading to a decline in shares.
Humana (HUM) vs. Anthem (ANTM): Which is Better Placed?
by Zacks Equity Research
Humana (HUM) and Anthem (ANTM) are poised to grow in the thriving health insurance industry. On a comparative evaluation, we try to discover which is a more profitable bet based on the fundamentals.
Anthem (ANTM) Up 13.2% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Anthem (ANTM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Healthcare Stocks in Focus on Price Transparency Rule
by Sapna Bagaria
Hospital stocks gain from a less-than-expected strict price transparency rule and health insurers' optimism on a likely rise in profitability from a low-cost plan.